ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,324Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 107

$1.31M Total Retail Price of All Prescriptions

Rank: 4 out of 107

689 Patients Receiving at Least One Drug in Part D
56%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 689 patients filled at least one prescription for a schedule two drug, compared to an average of 14%.

Schedule Three
Controlled Substances

7% of this provider’s 689 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 11,646 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 29.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
OMEPRAZOLE 933 394 1 6
RISPERIDONE 910 87 2 26
LEVOTHYROXINE SODIUM 892 388 3 1
METOPROLOL TARTRATE 652 509 4 7
POLYETHYLENE GLYCOL 3350 633 154 5 24
SIMVASTATIN 613 520 6 2
FUROSEMIDE 571 507 7 3
LEVETIRACETAM 536 79 8 44
DIVALPROEX SODIUM 509 76 9 55
ALENDRONATE SODIUM 452 177 10 35
SERTRALINE HCL 447 142 11 12
LISINOPRIL 444 328 12 4
AMLODIPINE BESYLATE 437 308 13 5
OLANZAPINE 408 68 14 57
LAMOTRIGINE 397 30 15 86
LACTULOSE 385 82 16 114
WARFARIN SODIUM 346 250 17 8
GABAPENTIN 344 168 18 11
CARBAMAZEPINE 330 46 19 133
CITALOPRAM HBR 328 215 20 9
QUETIAPINE FUMARATE 312 55 21 31
PRAVASTATIN SODIUM 304 125 22 32
HYDROCHLOROTHIAZIDE 284 133 23 14
ATORVASTATIN CALCIUM 270 93 24 17
RANITIDINE HCL 267 69 25 41
CARBAMAZEPINE XR 257 0 10 26 195
DONEPEZIL HCL 255 230 27 10
LOVASTATIN 251 81 28 51
TOPIRAMATE 218 0 29 182
TAMSULOSIN HCL 205 95 30 27
BENZTROPINE MESYLATE 197 46 R 31 131
MIRTAZAPINE 181 114 32 16
METOPROLOL SUCCINATE 179 131 33 15
KETOCONAZOLE 179 27 33 160
POTASSIUM CHLORIDE 177 98 35 18
PANTOPRAZOLE SODIUM 177 93 35 28
BACLOFEN 172 0 37 64
PROPRANOLOL HCL 164 0 38 145
LISINOPRIL-HYDROCHLOROTHIAZIDE 162 58 39 91
METFORMIN HCL 161 87 40 13
CHLORHEXIDINE GLUCONATE 157 26 41 183
IBUPROFEN 154 42 42 90
TRAZODONE HCL 152 107 43 22
ABILIFY 150 26 44 66
FLUOXETINE HCL 148 30 45 102
TRAMADOL HCL 147 139 46 23
LITHIUM CARBONATE 146 13 47 178
FAMOTIDINE 141 75 48 42
DIVALPROEX SODIUM ER 140 26 49 164
LATANOPROST 139 77 50 94
OXCARBAZEPINE 139 13 50 220
FLUTICASONE PROPIONATE 137 53 52 54
PHENYTOIN SODIUM EXTENDED 137 28 52 121
VIMPAT 133 0 54 285
FLUVOXAMINE MALEATE 132 0 55 220
CLOZAPINE 130 104 56 165
ZOLPIDEM TARTRATE 128 78 57 38
VESICARE 127 98 58 140
TRICOR 126 13 59 148
ENULOSE 125 25 60 212
SEROQUEL 122 26 61 87
ACETAMINOPHEN-CODEINE 120 84 S3 62 98
TEGRETOL XR 117 0 63 302
ESCITALOPRAM OXALATE 113 34 64 40
CLOTRIMAZOLE 110 13 65 229
BUSPIRONE HCL 110 32 65 82
VENLAFAXINE HCL ER 110 49 65 75
ATENOLOL 102 89 68 21
CARBIDOPA-LEVODOPA 101 75 69 56
HYDRALAZINE HCL 99 91 70 58
CLOPIDOGREL 98 74 71 29
GLIPIZIDE 97 84 72 46
NAMENDA 97 86 72 19
HALOPERIDOL 95 0 74 123
ISOSORBIDE MONONITRATE ER 92 92 75 30
CARVEDILOL 84 83 76 25
DIGOXIN 83 79 77 37
DILANTIN 82 16 78 252
VALPROIC ACID 82 16 78 209
IPRATROPIUM-ALBUTEROL 79 69 80 49
OXYBUTYNIN CHLORIDE ER 77 45 81 119
ENALAPRIL MALEATE 77 64 81 70
PLAVIX 75 61 83 43
CHLORPROMAZINE HCL 74 0 84 342
PAROXETINE HCL 73 20 85 80
CEPHALEXIN 73 33 85 120
FINASTERIDE 72 65 87 72
DOXAZOSIN MESYLATE 69 31 88 136
NEXIUM 68 11 89 61
LANTUS 68 55 89 34
PRIMIDONE 67 35 91 193
ZONISAMIDE 67 0 91 355
AMMONIUM LACTATE 66 12 93 280
LOXAPINE 65 0 94 360
NIFEDIPINE ER 63 26 95 110
ERYTHROMYCIN 63 26 95 253
METFORMIN HCL ER 63 37 95 207
FEXOFENADINE HCL 61 0 98 276
NAPROXEN 59 30 99 153
OXYCODONE-ACETAMINOPHEN 56 52 S2 100 53
FENTANYL 56 54 S2 100 50
HYDROCODONE-ACETAMINOPHEN 56 41 S3 100 20
LIPITOR 55 18 103 132
HYDROCORTISONE 54 13 104 181
ALBUTEROL SULFATE 54 13 104 67
GLYBURIDE 54 43 R 104 95
SELENIUM SULFIDE 54 0 104 378
OXYBUTYNIN CHLORIDE 54 25 104 118
TIMOLOL MALEATE 54 48 104 243
LIDODERM 53 50 110 77
NYSTOP 52 36 111 103
AMITIZA 52 0 111 169
CLONIDINE HCL 51 36 113 95
METOCLOPRAMIDE HCL 51 17 113 122
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.